-
YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from New Zealand
prnasia
August 10, 2021
YishengBio Co., Ltd announced that it received IND clearance for PIKA recombinant COVID-19 vaccine (CHO cell, S Protein) to conduct Phase I clinical trial from New Zealand Medicines and Medical Devices Safety Authority ("MEDSAFE"), which was following ...
-
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand
expresspharma
March 02, 2021
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
-
New Zealand approves COVID-19 vaccine, warns against nationalism
expresspharma
February 04, 2021
The World Health Organization has warned against “hoarding” as a growing number of countries agreed bilateral deals to buy millions of doses of COVID-19 vaccines.
-
New Zealand moves towards legalising medical cannabis
pharmaceutical-technology
December 12, 2018
New Zealand’s parliament has passed an amendment to the Misuse of Drugs Act 1975 that will allow terminally ill patients to possess and use cannabis....
-
Tandem announces Australia, New Zealand distribution deals
biospectrumasia
April 25, 2018
Under the terms of the arrangements, the diabetes divisions of AMSL and NZMS will perform all sales, marketing, and customer training and support for Tandem’s products in the regions.